KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zimmer Biomet Holdings (ZBH) Return on Sales (2016 - 2025)

Zimmer Biomet Holdings has reported Return on Sales over the past 17 years, most recently at 0.06% for Q4 2025.

  • Quarterly results put Return on Sales at 0.06% for Q4 2025, down 3.0% from a year ago — trailing twelve months through Dec 2025 was 0.09% (down 3.0% YoY), and the annual figure for FY2025 was 0.09%, changed.
  • Return on Sales for Q4 2025 was 0.06% at Zimmer Biomet Holdings, down from 0.12% in the prior quarter.
  • Over the last five years, Return on Sales for ZBH hit a ceiling of 0.22% in Q4 2023 and a floor of 0.04% in Q1 2022.
  • Median Return on Sales over the past 5 years was 0.08% (2024), compared with a mean of 0.06%.
  • Peak annual rise in Return on Sales hit 29bps in 2021, while the deepest fall reached -39bps in 2021.
  • Zimmer Biomet Holdings' Return on Sales stood at 0.02% in 2021, then surged by 48bps to 0.01% in 2022, then skyrocketed by 2653bps to 0.22% in 2023, then crashed by -56bps to 0.1% in 2024, then plummeted by -35bps to 0.06% in 2025.
  • The last three reported values for Return on Sales were 0.06% (Q4 2025), 0.12% (Q3 2025), and 0.07% (Q2 2025) per Business Quant data.